Lupin share jumps 3% on launching anesthesia injection in US

Lupin share jumps 3% on launching anesthesia injection in US

  Shares of Lupin Ltd rose 3% on 8 november  after the company announced the launch of Rocuronium Bromide injection, an anesthesia medicine, in the United States.  The launch came after Lupin’s alliance partner Caplin Steriles received approval from the United States Food and Drug Administration (USFDA), the global pharma major said in a filing … Read more